Insulin sensitivity of the human brain

Diabetes Research and Clinical Practice

Volumn 93, Issue SUPPL. 1, 2011, Pages

  Ketterer, Caroline ^a   Tschritter, Otto ^a   Preissl, Hubert ^a,b   Heni, Martin ^a   Häring, Hans Ulrich ^a   Fritsche, Andreas ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Brain; Diabetes mellitus; Insulin resistance

Indexed keywords

HUMAN INSULIN; INSULIN; INSULIN DETEMIR; PLACEBO; RECOMBINANT HUMAN INSULIN;

ALLELE; ARTICLE; BLOOD BRAIN BARRIER; BODY MASS; BOLD SIGNAL; BRAIN; COGNITIVE DEFECT; ELECTROENCEPHALOGRAPHY; ENDOCRINE FUNCTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; MAGNETOENCEPHALOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; SIDE EFFECT; SIGNAL TRANSDUCTION; WEIGHT GAIN;

BRAIN; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE;

EID: 84860390335     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/S0168-8227(11)70013-4     Document Type: Article

References (17)

1. Obici S, Zhang BB, Karkanias G, Rossetti L Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002, 8(12):1376-1382.
2. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW Central nervous system control of food intake and body weight. Nature 2006, 443(7109):289-295.
3. Hallschmid M, Schultes B Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?. Diabetologia 2009, 52(11):2264-2269.
4. Benedict C, Hallschmid M, Schultes B, Born J, Kern W Intranasal insulin to improve memory function in humans. Neuroendocrinology 2007, 86(2):136-142.
5. Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, et al. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 2008, 70(6):440-448.
6. Anthony K, Reed LJ, Dunn JT, Bingham E, Hopkins D, Marsden PK, et al. Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome?. Diabetes 2006, 55(11):2986-2992.
7. Tschritter O, Preissl H, Hennige AM, Stumvoll M, Porubska K, Frost R, et al. The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study. Proc Nati Acad Sei USA 2006, 103(32):12103-12108.
8. Dzoljic E, van Leeuwen R, de Vries R, Dzoljic MR Vigilance and EEG power in rats: effects of potent inhibitors of the neuronal nitric oxide synthase. Naunyn Schmiedebergs Arch Pharmacol 1997, 356(1):56-61.
9. Porubska K, Veit R, Preissl H, Fritsche A, Birbaumer N Subjective feeling of appetite modulates brain activity: an fMRI study. Neuroimage 2006, 32(3):1273-1280.
10. Guthoff M, Grichisch Y, Canova C, Tschritter O, Veit R, Hallschmid M, et al. Insulin modulates food-related activity in the central nervous system. J Clin Endocrinol Metab 2010, 95(2):748-755.
11. Tschritter O, Preissl H, Hennige AM, Sartorius T, Grichisch Y, Stefan N, et al. The insulin effect on cerebrocortical theta activity is associated with serum concentrations of saturated nonesterified Fatty acids. J Clin Endocrinol Metab 2009, 94(11):4600-4607.
12. Haupt A, Thamer C, Machann J, Kirchhoff K, Stefan N, Tschritter O, et al. Impact of variation in the FTO gene on whole body fat distribution, ectopic fat, and weight loss. Obesity (Silver Spring) 2008, 16(8):1969-1972.
13. Tschritter O, Preissl H, Yokoyama Y, Machicao F, Haring HU, Fritsche A Variation in the FTO gene locus is associated with cerebrocortical insulin resistance in humans. Diabetologia 2007, 50(12):2602-2603.
14. Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, et al. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry 2005, 13(11):950-958.
15. Fritsche A, Haring H At last, a weight neutral insulin?. Int J Obes Relat Metab Disord 2004, 28(Suppl 2):S41-S46.
16. Hallschmid M, Jauch-Chara K, Korn O, Molle M, Rasch B, Born J, et al. Euglycemic infusion of insulin detemir compared with human insulin appears to increase direct current brain potential response and reduces food intake while inducing similar systemic effects. Diabetes 2010, 59(4):1101-1107.
17. Tschritter O, Hennige AM, Preissl H, Porubska K, Schafer SA, Lutzenberger W, et al. Cerebrocortical beta activity in overweight humans responds to insulin detemir. PLoS One 2007, 2(11):e1196.